NeueHealth, Inc. (NYSE:NEUE - Get Free Report) CEO George Lawrence Mikan III sold 13,180 shares of the firm's stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $6.93, for a total transaction of $91,337.40. Following the transaction, the chief executive officer now owns 297,790 shares of the company's stock, valued at approximately $2,063,684.70. The trade was a 4.24 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink.
George Lawrence Mikan III also recently made the following trade(s):
- On Monday, March 10th, George Lawrence Mikan III sold 1,604 shares of NeueHealth stock. The shares were sold at an average price of $7.06, for a total value of $11,324.24.
- On Friday, March 7th, George Lawrence Mikan III sold 26,660 shares of NeueHealth stock. The shares were sold at an average price of $7.19, for a total value of $191,685.40.
- On Monday, January 6th, George Lawrence Mikan III sold 31,798 shares of NeueHealth stock. The stock was sold at an average price of $7.33, for a total value of $233,079.34.
- On Tuesday, December 17th, George Lawrence Mikan III sold 16,803 shares of NeueHealth stock. The stock was sold at an average price of $4.18, for a total transaction of $70,236.54.
NeueHealth Trading Up 0.2 %
NYSE NEUE opened at $6.75 on Friday. The stock's fifty day moving average price is $7.30 and its 200-day moving average price is $6.00. NeueHealth, Inc. has a 12 month low of $3.79 and a 12 month high of $7.66. The stock has a market cap of $55.96 million, a P/E ratio of -0.13 and a beta of 0.56.
Hedge Funds Weigh In On NeueHealth
Institutional investors have recently bought and sold shares of the stock. Partners Group Holding AG purchased a new stake in shares of NeueHealth during the third quarter worth about $463,000. Northern Trust Corp increased its stake in NeueHealth by 66.8% during the fourth quarter. Northern Trust Corp now owns 32,644 shares of the company's stock worth $242,000 after acquiring an additional 13,074 shares during the last quarter. Finally, Virtu Financial LLC purchased a new position in NeueHealth during the fourth quarter worth $76,000. 63.88% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Royal Bank of Canada decreased their target price on shares of NeueHealth from $8.00 to $7.00 and set a "sector perform" rating on the stock in a research report on Monday, December 9th.
View Our Latest Stock Analysis on NeueHealth
About NeueHealth
(
Get Free Report)
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
